🟢 Nyxoah is trading 11.28% up in pre-market with no confirmed company-specific catalyst

Nyxoah is trading at $1.48, up 11.28%, with no fresh company-specific announcement identified to explain its October 2 pre-market rise.

• Nyxoah’s previously announced CFO transition takes effect October 2; it was disclosed September 21 and does not establish a direct reason for the gain.
• Broader U.S. futures point to a firmer open: Nasdaq up 0.80% and Dow up 0.55%. This may support sentiment, though healthcare is weaker; no direct link to Nyxoah’s move is confirmed.